Bulimia Nervosa Clinical Trial
— PASOfficial title:
Engaging Latino Families in Eating Disorders Treatment
Promoviendo Alimentacion Saludable (PAS)"Promoting Healthy Eating" is a research project funded by the National Institute of Mental Health. The purpose of this study is to develop and test a treatment for eating disorders in Latina adults that is appropriate for their age and includes culturally appropriate family intervention.
Status | Completed |
Enrollment | 25 |
Est. completion date | March 2016 |
Est. primary completion date | March 2016 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - DSM-IV criteria for BN, BED, EDNOS (sub-threshold BN) - Latina - If taking antidepressant medication, stable dose for at least 3 months prior - Willingness to ask a family member or significant other to participate AND agreement of family member to participate Exclusion Criteria: - Any major medical condition that would interfere with treatment or require alternative treatment - Alcohol or drug dependence in the last three months - Current significant suicidal ideation - Developmental disability that would impair the ability of the participant to benefit from psychotherapy effectively - Psychosis, including schizophrenia, or bipolar I disorder - Pregnancy - Body mass index below 17.5 kg/m^2 - If taking antidepressant medication, doses are not stable; individuals taking any medications that can significantly affect appetite or weight. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | UNC Center of Excellence for Eating Disorders | Chapel Hill | North Carolina |
United States | University of North Carolina | Chapel Hill | North Carolina |
Lead Sponsor | Collaborator |
---|---|
Mae Lynn Reyes-Rodriguez, PhD | El Futuro, National Institute of Mental Health (NIMH), University of North Carolina, Chapel Hill |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | M-FED Questionnaire | 3 Month Follow-up | No | |
Primary | Change from Baseline in Eating Disorder Examination (EDE) Scores at End of Treatment | End of Treatment will be measured by the completion of the twenty-five (25) scheduled therapy session, regardless of treatment group. | Baseline, End of Treatment | No |
Secondary | Change from Baseline in Beck Depression Inventory-Revised (BDI-R) score at Week 6 of Treatment | Baseline, Week 6 | No | |
Secondary | Change from Baseline in Beck Depression Inventory-Revised (BDI-R) score at End of Treatment | End of Treatment will be measured by the completion of the twenty-five (25) scheduled therapy session, regardless of treatment group. | Baseline, End of Treatment | No |
Secondary | Change from Baseline in Beck Depression Inventory-Revised (BDI-R) score at 3 Month Follow-up | Baseline, 3 Month Follow-up | No | |
Secondary | Change from Baseline in the Symptom Checklist-36 (SCL-36) score at Week 6 of Treatment | Baseline, Week 6 of Treatment | No | |
Secondary | Change from Baseline in Symptom Checklist-36 (SCL-36) score at End of Treatment | End of Treatment will be measured by the completion of the twenty-five (25) scheduled therapy session, regardless of treatment group. | Baseline, End of Treatment | No |
Secondary | Change from Baseline in Symptom Checklist-36 (SCL-36) score at 3 Month Follow-up | Baseline, 3 Month Follow-up | No | |
Secondary | Change from Baseline in Family Support Questionnaire score at End of Treatment | End of Treatment will be measured by the completion of the twenty-five (25) scheduled therapy session, regardless of treatment group. | Baseline, End of Treatment | No |
Secondary | Change from Baseline in Family Support Questionnaire score at 3 Month Follow-up | Baseline, 3 Month Followup | No | |
Secondary | Change from Baseline in Family Cohesion (FC) score at End of Treatment | End of Treatment will be measured by the completion of the twenty-five (25) scheduled therapy session, regardless of treatment group. | Baseline, End of Treatment | No |
Secondary | Change from Baseline in Family Cohesion (FC) score at 3 Month Follow-up | Baseline, 3 Month Follow-up | No | |
Secondary | Change from Baseline in Family Burden Interview Scale (FBIS) score at End of Treatment | End of Treatment will be measured by the completion of the twenty-five (25) scheduled therapy session, regardless of treatment group. | Baseline, End of Treatment | No |
Secondary | Change from Baseline in Family Burden Interview Scale (FBIS) score at 3 Month Follow-up | Baseline, 3 Month Follow-up | No | |
Secondary | Change from Baseline in Family Score (FS) at End of Treatment | Baseline, End of Treatment | No | |
Secondary | Change from Baseline in Family Score (FS) at 3 Month Follow-up | Baseline, 3 Month Follow-up | No | |
Secondary | Treatment Adherence as of End of Treatment | Treatment Adherence will be measured positively if a participant has completed at least 80% of treatment (20 sessions or more) or negatively if less than 80% of treatment (19 sessions or less) has been completed. | Baseline, End of Treatment | No |
Secondary | Change from Baseline in Eating Disorder Examination Questionnaire (EDE-Q) score at Week 6 of Treatment | Baseline, Week 6 | No | |
Secondary | Change from Baseline in Eating Disorder Examination Questionnaire (EDE-Q) score at End of Treatment | End of Treatment will be measured by the completion of the twenty-five (25) scheduled therapy session, regardless of treatment group. | Baseline, End of Treatment | No |
Secondary | Change from Baseline in Eating Disorder Examination Questionnaire (EDE-Q) score at 3 Month Follow-up | Baseline, 3 Month Follow-up | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT04174703 -
Preparing for Eating Disorders Treatment Through Compassionate Letter-Writing
|
N/A | |
Terminated |
NCT04278755 -
Binge Eating & Birth Control
|
Phase 2 | |
Withdrawn |
NCT02978742 -
Evaluating and Implementing a Smartphone Application Treatment Program for Bulimia Nervosa and Binge Eating Disorder
|
N/A | |
Withdrawn |
NCT00988481 -
Topiramate Augmentation in Bulimia Nervosa Partial Responders
|
Phase 4 | |
Completed |
NCT00184301 -
A Comparison Study of Treatments Given to Patients With Concurrent Eating Disorder and Personality Disorder.
|
N/A | |
Completed |
NCT00522769 -
Cognitive Behavioral Therapy to Treat Bulimia Nervosa in Adolescents
|
Phase 1/Phase 2 | |
Completed |
NCT00304187 -
Effectiveness of Antibiotic Treatment for Reducing Binge Eating and Improving Digestive Function in Bulimia Nervosa
|
Phase 2 | |
Recruiting |
NCT04409457 -
Self-Control in Bulimia Nervosa
|
N/A | |
Recruiting |
NCT05509257 -
Naltrexone Neuroimaging in Teens With Eating Disorders
|
Early Phase 1 | |
Recruiting |
NCT05862389 -
Study on the Mechanism of Eating Disorder
|
||
Recruiting |
NCT05937243 -
Identifying Effective Technological-based Augmentations to Enhance Outcomes From Self-help Cognitive Behavior Therapy for Binge Eating
|
N/A | |
Recruiting |
NCT05728021 -
Smartphone-based Aftercare for Inpatients With Bulimia Nervosa
|
N/A | |
Completed |
NCT03781921 -
The Neural Bases of Emotion Regulation in Bulimia Nervosa
|
||
Completed |
NCT02553824 -
FDA Approved Medication to Reduce Binge Eating and/or Purging
|
Phase 1 | |
Terminated |
NCT04041024 -
Decision-making and Risk-taking in Bulimia
|
N/A | |
Completed |
NCT04265131 -
Emotion Regulation in Eating Disorders: How Can Art Therapy Contribute to Treatment Outcome?
|
N/A | |
Recruiting |
NCT06431854 -
Evaluation of a New Treatment Program for Adolescents With Eating Disorders: MINERVA Program
|
N/A | |
Recruiting |
NCT02960152 -
Periodontal Impact of Eating Disorders (the PERIOED Study)
|
N/A | |
Completed |
NCT00916071 -
Association Between Attention Deficit Hyperactivity Disorder and Bulimia Nervosa in Outpatients With Eating Disorders
|
N/A | |
Terminated |
NCT00308776 -
Cholecystokinin for Reducing Binge Eating in People With Bulimia Nervosa
|
N/A |